Transcutaneous Auricular Vagus Nerve Stimulation

Area of Science:

• Neuroscience
• Neuromodulation
• Epilepsy Treatment

Background:

• Invasive vagus nerve stimulation (VNS) is effective for drug-resistant epilepsy but has drawbacks like invasiveness and side effects.
• VNS targets the left cervical vagus nerve, activating afferent fibers to modulate brainstem and cerebral activity for anticonvulsive effects.
• Transcutaneous VNS (tVNS) explores the auricular branch of the vagus nerve as a non-invasive stimulation pathway.

Purpose of the Study:

• To evaluate transcutaneous vagus nerve stimulation (tVNS) as a non-invasive alternative to invasive VNS for drug-resistant epilepsy.
• To investigate the anatomical and functional basis for auricular vagus nerve stimulation.
• To compare the cerebral activation patterns of tVNS and invasive VNS.

Main Methods:

• Review of anatomical data on the auricular branch of the vagus nerve, focusing on thick-myelinated afferent fibers.
• Analysis of preclinical and clinical studies on vagus nerve stimulation, including functional imaging in humans.
• Assessment of safety and performance data from clinical trials investigating tVNS for epilepsy.

Main Results:

• The left auricular branch of the vagus nerve contains a significant proportion of thick-myelinated afferent nerve fibers.
• Auricular vagus nerve afferents project to the nucleus of the solitary tract, similar to cervical VNS.
• Cerebral activation patterns induced by tVNS and invasive VNS show resemblance.

Conclusions:

• Transcutaneous VNS of the auricular branch provides a non-invasive route to modulate neural pathways implicated in epilepsy.
• tVNS demonstrates potential as a safe and effective alternative for managing drug-resistant epilepsy.
• Further clinical trials support the application of tVNS in epilepsy treatment.